Ayush Licensing Process Made Easier In UP

Lucknow: The process of obtaining a license for the manufacture and sale of Ayurvedic medicines has now become even easier. In Uttar Pradesh, all applications can now be made online through the e-aushadhi portal. This step will bring transparency in the process of issuing licenses and curb corruption. Entrepreneurs will no longer have to face any difficulty for licenses.

Now applications for obtaining license for manufacturing and selling Ayurvedic medicines can be made only through e-auspicious portal. All regional Ayurvedic and Unani officers have been instructed to immediately register themselves on this portal.

He should register himself as a drug inspector. From October 14, only online applications for license will be accepted through this portal. The process of offline application will be completely abolished.

Instructions issued

These instructions were issued on Thursday by Ayurveda Director Manvendra Singh. All regional Ayurvedic and Unani officers have been instructed to check their ID and password on the portal in time and contact the Ayurveda Directorate in case of any problem.

Due to the ever-increasing demand for Ayurvedic medicines, the number of people seeking licenses for their manufacture and sale is increasing rapidly. In such a situation, this step has been taken to make the process of issuing licenses transparent.

Many times complaints are received against regional Ayurvedic and Unani officers that they are deliberately delaying the license. Complaints of corruption are also made. In such a situation, now entrepreneurs will not have to face any difficulty by applying for a license through e-aushadhi portal. On completion of the documents, the license will be issued to them within the stipulated time limit.

Related Posts

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

The Maharashtra Food and Drug Administration (FDA) seized 3,098.46 tonnes of food stock worth Rs 63.45 crore and suspended 954 food licences during a statewide enforcement drive in the past…

Stents to syringes: Serious harm reports surge, but makers remain unnamed

6-year data disclosed first time by Indian Pharmacopoeia Commission on CIC order The Indian Pharmacopoeia Commission (IPC) has, for the first time, disclosed the number of Serious Adverse Events (SAEs)…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

Stents to syringes: Serious harm reports surge, but makers remain unnamed

Stents to syringes: Serious harm reports surge, but makers remain unnamed

NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

Medicines that cure Us are making Our Environment Sick

Medicines that cure Us are making Our Environment Sick